Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Mar;16(2):100-110.
doi: 10.1370/afm.2179.

Use of Asthma APGAR Tools in Primary Care Practices: A Cluster-Randomized Controlled Trial

Affiliations
Multicenter Study

Use of Asthma APGAR Tools in Primary Care Practices: A Cluster-Randomized Controlled Trial

Barbara P Yawn et al. Ann Fam Med. 2018 Mar.

Abstract

Purpose: The purpose of this study was to assess patient and practice outcomes after introducing the Asthma APGAR (Activities, Persistent, triGGers, Asthma medications, Response to therapy) tools into primary care practices.

Methods: We used a pragmatic cluster-randomized controlled design in 18 US family medicine and pediatric practices to compare outcomes in patients with persistent asthma aged 5 to 45 years after introduction of the Asthma APGAR tools vs usual care. Patient outcomes included asthma control, quality of life, and emergency department (ED), urgent care, and inpatient hospital visits. The practice outcome was adherence to asthma guidelines.

Results: We enrolled 1,066 patients: 245 children, 174 adolescents, and 647 adults. Sixty-five percent (692 patients) completed both baseline and 12-month questionnaires, allowing analysis for patient-reported outcomes. Electronic health record data were available for 1,063 patients (99.7%) for practice outcomes. The proportion of patients reporting an asthma-related ED, urgent care, or hospital visit in the final 6 months of the study was lower in the APGAR practices vs usual care practices (10.6% vs 20.9%, P = .004). The percentage of patients with "in control" asthma increased more between baseline and 1 year in the APGAR group vs usual care group (13.5% vs 3.4%, P =.0001 vs P =.86) with a trend toward better control scores and asthma-related quality of life in the former at 1 year (P ≤.06 and P = .06, respectively). APGAR practices improved their adherence to 3 or more guideline elements compared with usual care practices (20.7% increase vs 1.9% decrease, P = .001).

Conclusions: Introduction of the Asthma APGAR tools improves rates of asthma control; reduces asthma-related ED, urgent care, and hospital visits; and increases practices' adherence to asthma management guidelines.

Trial registration: ClinicalTrials.gov NCT01446315.

Keywords: asthma; asthma control; asthma management; asthma tool; guideline; implementation; outcomes; practice-based research; pragmatic research; primary care; protocol; randomized clinical trial.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Barbara P. Yawn served on asthma and COPD advisory boards for Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Teva. Young Juhn received support for asthma research from Genentech. All other authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Asthma APGAR patient form.
Figure 2
Figure 2
CONSORT diagram for cluster-randomized trial of APGAR tools implementation in primary care. APGAR = Activities, Persistent, triGGers, Asthma medications, Response to therapy; CONSORT = Consolidated Standards Of Reporting Trials.
Figure 3
Figure 3
Primary outcomes: asthma-related ED, urgent care, and hospital visits, and asthma control (rates of “in control”). ACT = Asthma Control Test; APGAR = Activities, Persistent, triGGers, Asthma medications, Response to therapy; ED = emergency department. a ACT score ≥20. Note: Rates of asthma-related ED, urgent care, and hospital visits compared with χ2 test. Rates of asthma control compared with McNemar test.

Similar articles

Cited by

References

    1. Hedman L, Bjerg A, Lundbäck B, Rönmark E. Conventional epidemiology underestimates the incidence of asthma and wheeze-a longitudinal population-based study among teenagers. Clin Transl Allergy. 2012; 2(1): 1. - PMC - PubMed
    1. Akinbami LJ, Sullivan SD, Campbell JD, et al. Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol. 2012; 129(3) (Suppl): S49–S64. - PMC - PubMed
    1. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2009. Vital Health Stat 10. 2010; 247(247): 1–82. - PubMed
    1. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999; 104(5): 957–963. - PubMed
    1. To T, Dell S, Dick P, Cicutto L. The burden of illness experienced by young children associated with asthma: a population-based cohort study. J Asthma. 2008; 45(1): 45–49. - PubMed

Publication types

MeSH terms

Associated data